Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Oceanlow1. I was trying to be nice and put the team back together. I see it cannot be done. Before you sell IMUN and buy ITL you should read this link that I provided for you. Seth Shaw and Antonio Treminio have both been accused by you as a Pump & Dumper. After you read this link we will finally know who had the skills to know how to Pump & Dump and who was actually prosecuted for it. Sorry you have not learned anything.
http://openjurist.org/989/f2d/971/united-states-v-l-gruenberg
Blackcat7717
To MHB & Oceanlow1, IMUN is now a 9% shareholder in ITL for the long term. IMUN has applied for a name change to Tauriga Science, Inc. Anyone who has read any of your previous posts on this board knows that both of you have a direct line to Dr. Harnoy. It would be helpful to IMUN & ITL investors if you could share your influence to keep IMUN investors informed on any new developments in ITL.
1) Do you know if the trials is Bangkok will start in April?
2) Do you know how many patients will be participating in the Bangkok Trials?
3) Do you know if Dr. Harnoy has enought money to start the trials?
4) Do you know if Dr. Harnoy will be updating his website soon?
http://www.immunovative.co.il/.
In your quest for getting to the truth you were both pretty hard on Seth Shaw & Antonio Treminio. Are you going to use the same tenacity on Dr. Harnoy? As you know, Dr. Harnoy (ITL) is a private company. He is not held to the same scrutiny as a Public Company like IMUN. Will you see to it that IMUN investors are informed and protected with furtue developments in ITL?
At this time the only way small investors can participate in the success of ITL is by purchasing shares in IMUN (Tauriga Science, INC.).
Now is your opportunity to use all of your influence to protect IMUN investors along with yourself.
Blackcat7717
ZALICUSLICIOUS my update has been posted on SCRH.
Blackcat7717
TO ALL NEW INVESTORS IN SCRH A SUMMARY FROM 2009.
Scores Holding Co. grants the exclusive worldwide license to use and to grant sublicenses to use the "SCORES" trademarks in connection with the ownership and operation of upscale, adult-entertainment cabaret night clubs/restaurants and for the sale of merchandise by such establishments. Merchandise must relate to the nightclub that sells it, and may be sold at the nightclub, on an internet site maintained by the nightclub, by mail order and by catalogue. To further this end, we entered into the Master License with EMS and depend upon our relationship with EMS. The term of the Master License is twenty years. EMS has the option to renew the Master License for six consecutive five-year terms. The Company will receive royalties equal to 4.99% of the gross revenues of all sublicensed clubs that are controlled by EMS. Pursuant to the terms of the Master License, EMS has granted sublicenses to six nightclubs to use the "SCORES" trademark
1) ROBERT M. GANS ACQUIRES SCRH STOCK FROM OLD MANAGEMENT IN 2009 AND TAKES CONTROL FOR $500,000.
2) MR. GANS PURCHASED A BUILDING FOR 10 MILLION DOLLARS IN NYC THAT WILL HOUSE SCORES N.Y.C .
3) MR. GANS COMPLETES A 1 MILLION DOLLAR RESTORATION ON THE NY CLUB AND CLOSES THE OLDER NYC CLUB.
4) MR. GANS SETTLES A LAWSUIT AGAINST OLD MANAGEMENT THAT WAS FILED IN 2007 FOR $500,000 (GANS TOOK OVER 2009).
5) MR. GANS OWNS AN OPERATES ROBERT'S STEAK HOUSE LOCATED IN OR NEAR ALL SCORES GENTLEMAN CLUBS.
6) MR. GANS ALSO OWNS A PRIVATE CLUB IN NYC CALLED (PENTHOUSE EXECUTIVE CLUB) www.penthouseexecutive.com
7) MR. GANS OWNS 115 MILLION SHARES OF SCRH. THE OUTSTANDING SHARES ARE 165 MILLION. FLOAT CURRENTLY 50 MILLION.
8) MR. GANS WITHIN THE LAST FEW MONTHS OPENED A 8000 SQ FOOT ROBERT'S STEAK HOUSE IN THE TAJ MAHAL IN ATLANTIC CITY N.J.
9) MR. GANS WILL ALSO OPEN A 20 MILLION DOLLAR SCORES GENTLEMAN CLUB ON JULY 4, 2013 IN THE TAJ MAHAL IN ATLANTIC CITY N.J.THIS WILL BE THE FIRST OF IT'S KIND IN ATLANTIC CITY N.J.
10) SCRH ANNOUNCED RECENTLY A NEW CLUB IN DETROIT IN THE NEAR FUTURE.
11) SCRH CURRENTLY HAS 5 GENTLEMEN CLUB'S OPEN: NYC, TAMPA,CHICAGO,BALTIMORE,NEW ORLEANS, ATLANTIC CITY 7/4/2013, DETROIT (SOON).
12) SCRH RECENTLY HIRED A LARGER ACCOUNTING FIRM TO BRING THE SEC FILING'S CURRENT.
13) SCRH IS LATE ON 3 QUARTERS AT THIS TIME. SCRH WILL REMAIN A REPORTING COMPANY.
14) THE MAIN WEBSITE FOR SCRH HAS NOT BEEN UPDATED YET, BUT IT IS ONLINE WWW.SCORESHOLDING.COM .
15) THE 5 WEBSITES BELOW LIST ALL THE CURRENT GENTLEMEN CLUBS:
WWW.SCORESNY.COM WWW.SCORESTAMPA.COM WWW.SCORESCHICAGO.COM WWW.SCORES-BALTIMORE.COM WWW.SCORES-NEWORLEANS.COM
IN CONCLUSION:
THE CURRENT PRICE OF SCRH IS BID .028 ASKED 0.034. THIS INVESTMENT IS HIGHLY SPECULATIVE. HOWEVER,THE COMPANY HAS BEEN IN BUSINESS SINCE 9/21/1981. WITH NEW MANAGEMENT SINCE 2009, A NEW ACCOUNTING FIRM. ROBERT GANS HAS USED A GREAT DEAL OF HIS MONEY SINCE 2009. THIS COULD BE A VERY INTERESTING INVESTMENT.
BLACKCAT7717
Zalicuslicious, I will post a summary on Investorshub message board for SCRH going back 4 years. Badman is the moderator and gets info all the time.I have been in this stock for many years. It will be worth it to go back and read all the posts since Robert
M. Gans took the company over in Jan 2009. (I Use strick limits near the bid) and make sure you take the time to do your DD.
Blackcat7717
Zalicuslicious, This is a guess on the name and symbol
change. I have been checking this address below daily. It might
take 2 weeks or less from today. I am sure that IMUN will issue
a Press Release as soon as it is official.
http://www.otcmarkets.com/marketActivity/company-name-changes?search=imun&searchType=symbol
Check out Investorshub on one of my long time favorites (SCRH)
All time high $3.45 LOW .005. Read some of the posts.
Thinly traded waiting for the opening on July 4th, Taj Mahal.
Blackcat7717
Zalicuslicious, Do you think someone on this board is exhibiting symptoms of Dyslexia?
Dyslexia is a very broad term defining a learning disability that impairs a person's fluency or comprehension accuracy in being able to read and most importantly understand the facts. Does this sound like anyone who has posted to this board?
My Mother often told me just because someone repeats a lie over and over, that does not make it true. (P.S. I am not talking about the President of the U.S.)
Blackcat7717
OceanLow1 On October 4 2010 IMUN was trading at $.045 cents.
it is currently at $.055. During the same time period IMUN is up
and ITL is down.
Blackcat7717
Zalicuslicious, You must be a very successful person! You know
how to get to the point with so few words.
Good Luck SETH SHAW.
Long and Strong
Blackcat7717
Zalicuslicious, I pulled this info off an older press release.
ITL has previously released that it has been granted regulatory clearance from Thailand authorities to advance its lead AlloStimâ„¢ immunotherapy product candidate to Phase II/III development. The details of the Study design are now available to the public on the ClinicalTrials.gov website. The primary end-point of the Study is overall survival. The study has been powered to detect a difference of 50% or greater in overall survival between the treatment and control arms. If successfully executed and the pre-defined overall survival end-point reaches statistical significance, ITL expects that the clinical data from this trial can be used to support possible marketing applications for AlloStimâ„¢ in the USA, EU and other jurisdictions. The clinical trial is scheduled for launch in April 2013. The approved AlloStimâ„¢ Phase II/III clinical trial will be conducted at the National Cancer Institute of Thailand ("NCI-Thailand") located in Bangkok, Thailand and the Principal Investigator will be Wirote Lausoontornsiri, MD, a US licensed physician that is board certified in hematology/oncology and serves as the Head of the Clinical Trials and Academic Research Unit at the NCI-Thailand.
Dr. Michael Har-Noy, CEO and founder of ITL, stated: "We are currently preparing our manufacturing and clinical operations to conduct this advanced clinical trial. Our plan is to launch this trial on or about April 2013. We are working carefully to put in place the quality assurance procedures and monitoring procedures necessary to assure the safety of the drug production, the integrity of the data and that the Study is conducted in compliance with international standards for Good Clinical Practices (GCP). The Study will have an independent Data Safety Monitoring Board (DSMB) assigned and will be regularly audited by experienced independent third party professionals."
Blackcat7717
Oceanlow1 The agreement could not go forward when DR. Harnoy refused to provide any information regarding the status of the hold with the FDA. Plus, he did not Publish the results for PEER Review on the 42 patients in Carlsbad Calif. Trials. At all the PRESENTATIONS Dr. Harnoy made many statements to investors that the FDA hold would soon be lifted and the Carlsbad results would soon be published. In both of these cases he might of told people, he might have put out a newsletter. However, he DID NOT post this information in any Medical Journal for Peer Review and
would not document any FDA communication's with IMUN regarding the HOLD. The stock dropped both in ITL ($4.00 to 1.00) and IMUN from $.25 cents to .05. when the Doctor refused compliance and announced he was not waiting for the FDA. He decided on his own to start the trials in BANGKOK in April. (That is what I read from this board). That was a sign to all investors that something was wrong.
Dr. Harnoy wanted more than $3.7 million dollars without providing any of this information. The agreement set out several stages of performance. The stages were money for results, money for results, This was very clear. As a public company IMUN's responsibility is to protect it's shareholders. Can you imagine
what would of happened if IMUN gave ITL 10 Million Dollars and the verbal information on the drug turned out to be false? What questions would you be asking NOW? At least now Seth Shaw has provided his shareholders with a safety net. IMUN has a settlement of 9% of ITL and SETH is working towards merging another company with IMUN. You will all come to realize what Seth has accomplished in a very short period of time.
Blackcat7717
Oceanlow1, IMUN raised $3.7 for ITL. which equals a 9% interest. If ITL did not file the Wrongful Termination Notice IMUN would have raised the additional $6.3 Million dollars equaling 25% for a total of 10 Million dollars. It is ITL's job now to raise the money for all investors. A 9% interest is fine, lets move on.
Perhaps DR. Harnoy has already been approached by other investors. He could have been offered more money to cancel the contract he had with IMUN. The terms of the settlement agreement will soon be over between IMUN & ITL. I am sure we will hear from DR. Harnoy soon. The trials in Bangkok will start in April.
Let's hope they are successful.
Blackact7717
Geo 7, If you spent the time reading the 10Q you would have found
that the company raised $2,285,127 @ $.10 and $5,190,632 between
$.10-.15 cents. This Totals $7,475,590. Now if you cannot read
the Quartly report I understand. The agreement with ITL was signed
on Dec 9, 2011. These fiqures are listed under the Sale of Common Stock under a Private Placement in 2 locations. Your next question
will be where is the rest of the money? It is clear that you do not know what it takes to run a Public Company with all the expenses of Travel,Legal, SEC filings, Fund Raising Presentations,ect.ect.ect.
Blackcat7717
For all Investors that own IMUN or ITL. I want to thank all of you for your positive comments. Seth Shaw has been doing business with many Institutional investors for years. Seth will use his many years of experience to move IMUN in a different direction. IMUN is a public company it is not wise to put all your eggs in one basket.
That is why Seth is moving in a different direction to accomplish 2 goals:
1) Create shareholder value in the Short & Long term by merging IMUN with another company.
IMUN shareholders need another company to rely on if something should go wrong with ITL's trials in Bangkok.
This is a smart move on Seth's part to protect shareholder value.
2) To make as much money as possible with our 9% ownership in ITL for the $3.7 Million Dollars we invested.
Many questions have been raised on this message board as to why we do not own 25% of ITL. The balance of 16% ended when the Wrongful Termination Notice was filed by ITL. (Remember if we did own 25% of ITL we would have had to raise another $6.3 Million dollars).
It is now ITL's job to raise additional money and I think they
will have no trouble doing so. ITL now works for IMUN rather than IMUN working for ITL.
I think investors that own both IMUN & ITL will be carrying less risk of capital the way we are going to be set up now. It will not be long before everyone on this board will be giving Seth Shaw the support he well deserves.
It will be Dr. Harnoy's responsibility to now inform IMUN as a shareholder with any progress he is having with ITL. This is exactly what Seth Shaw has been doing for us all along.
As part of the settlement with ITL, IMUN will soon have to change the name of the company.
Long and Strong GLTA
Blackcat7717
MHB & Oceanlow1, Please help me out with Neuvo_HongKong.
If you are in the medical field can you help him out?
A few months ago Dr. Harnoy had a Cure for Cancer. Now
Neuvo_HongKong calls our 9% in ITL just a piece of paper. Do you guys agree or disagree with him? He does not believe it was ITL/Dr. Harnoy who filed the Wrongful Termination Notice. He read the News Release and still does not believe it. He wants to attack me personally and I have no power to make any decisions in the operation of IMUN. I am just a loyal investor and I believe Seth Shaw can turn IMUN around.
Blackcat7717
For those of you who did not read this in the last 10 Q filed.
On February 19, 2013, the Company and ITL entered into a settlement agreement whereby the parties have agreed to the following: (1) the Company will submit a letter to the Court advising the Court that the parties have reached a settlement and that the Company is withdrawing its motion, (2) ITL will pay the Company $20,000, (3) ITL will issue to the Company, ITL’s share capital equivalent to 9% of the issued and outstanding shares of ITL, (4) IMUN WILL CHANGE IT'S NAME and (5) the settling parties agree that the license agreement will be terminated.
IMUN will now divorce itself from ITL. IMUN will remain in the same BIO space with another company in the near future. IMUN will retain 9% interest in the issued and outstanding shares of ITL. We will be a shareholder of ITL at the cost of $3.7 MILLION DOLLARS.
It will be ITL responsibility to raise funds and be successful in the Bangkok trials. We will see if DR. Harnoy has something or not after trials results are reported.
Long and Strong for all IMUN Shareholders.
Blackcat7717
Geo7 Are you saying 9% ownership in ITL is worth nothing.
Dr. Harnoy values ITL at 41 Million. IMUN owns 9% of ITL. That puts IMUN as a holding company with a valuation of $3.7 Million Dollars currently. You owe SETH SHAW an apology if you are an IMUN shareholder (with I doubt). I have a great deal of respect for those have come forward and made an apology to SETH SHAW.
Blackcat7717
Neuvo HongKong READ THIS AND THEN TELL ME WHO FILED THE WRONGFUL TERMINATION NOTICE!
Immunovative Inc. Responds to Wrongful Termination Notice of License Agreement and Demands Immediate Return of $3.7 Million USD Due to Multiple Contractual Breaches by Israeli Based Immunovative Therapies Ltd.
3:26p ET January 11, 2013 (Market Wire) Immunovative, Inc. ("IMUN" or the "Company") (OTCQB: IMUN) today announced that the Company has responded to the purported termination notice sent to IMUN by Immunovative Therapies Ltd. ("ITL") on January 08, 2013 ("Notice of Termination of License Agreement per Section 10.3.2") from Dr. Michael Har Noy acting on behalf of ITL. In its response the Company set forth facts showing that it has not breached any material terms or covenants of the license agreement and further asserted that ITL has committed multiple breaches of the license agreement. IMUN is considering seeking legal remedies against ITL, including the immediate disgorgement of approximately $3.7 million previously paid to ITL and damages incurred by the Company.
Seth Shaw, CEO of IMUN, stated: "In our view, the evidence is clear and incontrovertible that our company never breached our material obligations under the December 2011 license agreement with ITL. We believe that there is no reasonable interpretation of the license agreement in which our Company would have been obligated to pay ITL more than $2,450,000 USD at this point in time. The fact that our Company has advanced ITL approximately $3,700,000 USD towards the license agreement demonstrates the great level of importance and confidence that our management put in the relationship with ITL." Shaw continued, "Under these circumstances, sending IMUN a wrongful termination letter was a breach in itself of the license agreement by ITL. We believe the Company is in full compliance with License Agreement. We are carefully considering the most effective remedies available to us."
About Immunovative, Inc.: On December 12th, 2011, Immunovative, Inc. ("IMUN") signed an exclusive License Agreement (the "License Agreement") with Immunovative Therapies, Ltd. ("ITL"). Under the terms of the License Agreement, IMUN has been granted an exclusive, worldwide license to commercialize any products covered under ITL's current issued and pending patent application portfolio, as well as the rights to any future patent applications, including improvements or modifications to the existing applications and any corresponding improvements or new versions of the existing products. Please visit IMUN's website at www.imun.com.
About Immunovative Therapies, Ltd.: Immunovative Therapies, Ltd. is an Israeli biopharmaceutical company that was founded in May 2004 with financial support from the Israeli Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world-renowned Israeli technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstanding incubator project of 2006, awarded by the Office of the Chief Scientist. ITL specializes in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for treatment of cancer and infectious disease. Please visit ITL's website at: www.immunovative.co.il
DISCLAIMER
OceansLow1, You just do not get it. Seth's job is over regarding ITL. Dr. Harnoy made sure of that by filing The Wrongful Termination Notice. We are simply a 9% shareholder in ITL. Dr. Harnoy's job is now to raise funds and PUMP. IMUN is now a holding company and will now go in whatever direction they want and make acquisitions.
Blackcat7717
OCEANLOW 1, Sorry to hear you have an ANGER MANAGEMENT PROBLEM. You can take medication for all that anger, or I have a simple suggestion where to direct that anger. Place a market order for 1 MILLION SHARES of IMUN. Your average cost per share should be about 10 CENTS. The total cost to you will be about $100,000 dollars. Put these shares away like you said you were going to do. You can SELL them 1 year from now at $5.00 per share for a total of $ 5 Million dollars. That would drain all that anger OUT OF YOU. "WAKE UP YOU FOOL", SETH is working for all of us DAY AND NIGHT 7 DAYS A WEEK. You owe SETH SHAW an apology.
(NOTE:)THE ONLY PROBLEM I SEE WITH MY SUGGESTION IS THAT YOU WILL NOW HAVE TO PAY A LARGER CAPITAL GAIN TAX. INSTEAD OF 15% YOU WILL HAVE TO PAY 20% LONG TERM.
Blackcat7717
MHB, I am sure that SETH SHAW will truly appreciate your comments and your apology.
Blackcat7717
Oceanlow1, What is wrong with you? Why would you want IMUN to file Chapter 11 Bankruptcy?You have posted on this board many times that you own a large position in both companies. You should be jumping for joy that the lawsuit has been settled. SETH SHAW has posted on this board several times and has kept his shareholders informed. (This is not normal practice for a CEO to post on a message board) IMUN shareholders have invested $3,7 MILLION DOLLARS and SETH SHAW has recovered a 9 % stock position in ITL . In your OPINION you have stated that ITL is worth BILLIONS of dollars. As a duel shareholder you should have a good word for both SETH SHAW & DR. HARNOY for reaching a settlement. Instead you want IMUN to file Chapter 11 Bankruptcy. (STOP WHINING)
We have heard from Seth, now is a good time to hear from Dr. Harnoy on this message board. ITL has an ownership of 91%. Dr. Harnoy has an opportunity to tell us how he intends to create value for ITL & it's shareholders. You posted that Seth Shaw did not have the ability to bring this lawsuit to a settlement. You were WRONG. You must be representing SHORT SELLERS. I have never in my lifetime ever heard anyone who wanted to destroy the very stock that he owns.
Blackcat7717
Hello Oceanlow1, Mhb & Geo7. Do you have a response to Neuvo_HongKong post? You are shareholders in both of these companies. Will you take his advice and sell your shares?
Are you ready to support Seth Shaw NOW?
Blackcat7717
To All Investors: DOC21 posted this info on 2/16/13 #897.
THIS is what excites ME:
If the Phase II/III clinical trial (Thailand or US, doesn't matter), comes about, the results will likely be dramatic, as Allostim worked best in the HER2+ breast cancer patients (the worst kind). If it comes to market, it will be competing in an essentially empty field, as nothing much works for late stage breast CA. It could therefore EASILY surpass $1 billion in sales in a short time (Avastin did over $7 billion in 1 year). Now, the market cap of a new, successful biotech often is 10-20 times gross sales. Assuming 10 times, then ITL could easly be worth 10 billion in a short time. IMUN could be as much as 25% of ITL if the deal works out. This would would make IMUN about $2.5 billion, and with about 200 million shares, would make a share price of $12.50!!! Now if Allostim is used for other cancers (which it will be), well, sky's the limit...
I sure hope this works out - we'll all be rich...
DOC21
His post stated IMUN could go to $12.50 with a 25% interest in
ITL. IMUN currently owns a 9% interest in ITL with this settlement. That works out to approx. $5.00 a share for IMUN with 200 million shares out. (assuming the drug works) This does not take into account when our GREAT CEO SETH SHAW is successful in making an acquisition of any other company in the Biotech space.
This is all great news for IMUN Shareholders.
Blackcat7717
Doc21, We are in FULL agreement. I too would like to see this settled. Dr. Har-Noy will not come to the table to honor his obligation. He was happy to receive 4 MILLION DOLLARS from IMUN.Doctor Har-Noy is the one who filed the Wrongful Termination Notice not IMUN. Now all of a sudden SETH SHAW & ANTONIO TREMINIO are the bad guys. It is amazing, after IMUN raised 4 Million dollars, and they were on schedule to raise an additional 6 MILLION DOLLARS more for ITL. The Doctor pulls this stunt of withdrawal.You know him, give him a call to identify his motive. I will bet some other company offered him a great deal more money. That is why he is willing to expose his past. As a shareholder I also would like to see a fair settlement to this lawsuit.
Blackcat7717
To all investors, We finally exposed who GEO7 is. GEO7 is Dr. HAR-NOY. Just to let you know, We have been investigating you Dr. Har-Noy and we have a file 2 miles high. We cannot wait for you to be sworn in under oath. Anyone notice GEO7 (DR. HAR-NOY) cannot respond when someone counters his posts? His posts are always very late. (East Coast Time). The GREAT DOCTOR (OR IS HE A REAL DOCTOR) will be exposed. He states he has deep pockets, I guess he does. He filed a WRONGFUL TERMINATION NOTICE against IMUN shareholders and pocketed the money. Now he is using our 4 MILLION DOLLARS that IMUN raised towards the merger between ITL & IMUN shareholders to litigate against us. GEO7/DR. HAR-NOY your time is running out.You have a chance to do what is right then you and IMUN can move on.
Blackcat7717
TO ALL IMUN SHAREHOLDERS. Pour yourself a glass of wine, break out the cheese and crackers, make yourself comfortable. Now I suggest you spend some time reading the posts on Yahoo finance message board regarding IMUN. The 3 Amigos, MHB,Oceanlow1 & Geo7 have been busy trying to convince the Yahoo board about how Great DR. Harnoy is and how Bad Seth Shaw and Antonio Treminio are without success. MHB,Oceanlow1 & Geo7 are posting on Yahoo finance under different names. Looks like we drove them off by exposing their plan to destroy IMUN.
Blackcat7717
Wildcat, on a serious note. You might be an old guy from
Wall Street,but you make PURRRRFECT sense to me. Let's hope a
settlement is possible before we go to trial.
Blackcat7717
Did anyone from this board write this post on YAHOO this morning regarding Attorney John E. Lux? Please come forward. Is this the attorney that is going to save ITL and IMUN shareholders?
JOHN E. LUX -- BOZO THE CLOWN OF THE LEGAL PROFESSIONeffernett4112 by effernett4112 . Feb 14, 2013 5:37 AM . Permalink
.This John E. Lux is probably the lowest level securities attorney Ive ever seen. Ive seen people sell their integrity for low prices but this guy takes the cake. He should look in the mirror and vomit all over his dump of an office. He is a clown, a 10th rate attorney (not even a 9th rate attorney). That $10,000 reward press release was the funniest and most pathetic thing Ive ever seen. The guy is representing a king pen criminal and is administering a reward for the criminal. He has brought the legal profession to the lowest levels imaginable. And maybe he will find out who hacked Har Noy's computer. I know who!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! The same guy who sold jack the beanstalk. This John E. Lux guy is about as intimidating as a my little pony toy. Ive never seen such desperation on behalf of an ambulance chaser securities attorney and a career criminal who has just been exposed. Lux and Gruenberg - - A real DREAM TEAM:)
Sentiment: Hold
Geo7 Did the Cat bite your tongue and strike a nerve. It sounds like you are tongue tide. Perhaps you can ask Oceanlow1 to help you put a sentence together and also help you with your grammar. "He did it for me". You keep calling IMUN a shell. IMUN has a viable claim against ITL who graciously took 4 MILLION DOLLARS from IMUN shareholders under false pretence. I think you could call this an ass-t. I ask all investors to question the MOTIVE, MOTIVE, MOTIVE of GEO7, Oceanlow1 and MHB. All 3 investors are attacking the CEO'S of IMUN on this and other boards. They claim they are investors in IMUN. Why would they go out of their way to destroy the CEO'S and anyone who invested in IMUN stock? I did ask these 3 investors if they were so unhappy to sell their stock in IMUN and buy ITL stock. The response I got is NO. Remember I said question the motive. Here is a possibility! "QUID PRO QUO" from ITL in exchange for attacking and destroying the CEO'S and IMUN. When the smoke clears the courts will decide. IMUN will either own stock in ITL or ITL will have to return the 4 Million Dollars received from IMUN. IMUN should be seeking an alternative direction to create shareholders value. In the end, the assassins will move on to seek and destroy a NEW target and ride off into the SUNSET. Investors who stood by IMUN will not only survive they will be VICTORIOUS.
LONG AND STRONG
MEOOOOOWWW BLACKCAT7717
Oceanlow1, Geo7, & MHB. You all cease to amaze me. You claim you are investors in IMUN. I think not. I never saw a person attack the stock he owns. I am long IMUN. I pray everyday for a settlement between IMUN & ITL. Something is just not right. Is it
possible that all 3 of you are short IMUN? Hmmm I wonder.
"LATER".
Blackcat7717
How is that possible?
How is that possible if Dr. Har-Noy is offering the $10,000 Reward
with IMUN money.
This reward program is sponsored by Dr. Har-Noy, who will offer a $10,000 reward for information leading to arrest and conviction of any person who has committed criminal actions on himself or any company with which he is associated. The reward program will be administered by attorney John E. Lux, who will provide full information on the program to any informants. All reports will be held in confidence.
Blackcat7717
MHB,Did I not ask you 1 month ago to use your influence on Dr. Har-Noy to offer an olive branch to IMUN by retracting the Wrongful Termination Notice. I Also suggested you ask him to set up a conference call with both Law firms including IMUN and the FDA. Give me a reason (without calling them names) why Seth Shaw and Antonio Treminio would not want to make a great deal of money and see their stock go to $10.00 (as you stated). Why would they be satisfied with a P & D and make only $.15 profit.I have been in this stock for a long time. I think we both would like to see IMUN stock go to $2.00 or more per share. This is NOT going to happen if you do not get the Doctors Lawyers to contact IMUN Lawyers first.You stated, that Dr.Har-Noy has nothing to hide. This gives you a chance to have the Doctor prove it. He has time to speak to the FBI, SEC, the Canadian Law Enforcement. However, he has no time to speak to his Lawyers to settle this dispute. I cannot influence IMUN a Public Company with more than 1000 shareholders. You might be able to influence ITL a private company which has fewer shareholders. A Public Company has different rules and regulations to follow. I suggest you stay off the board, make the call and use all that energy and influence you have to fix this right now with Dr. Har-Noy. You say you know that Allostim works. If the drug is real you should want to help Cancer Patients and not fan the flames of litigation. Many people will die if this drug has merit and never makes it to market. That will be on Dr. Har-Noy's shoulders not IMUN. He was the one that filed The Wrongful Termination Notice after receiving 4 Million dollars. It only takes 2 Million dollars to start the trials in Bangkok not 4 million.
Blackcat7717
MHB SELL SELL YOUR STOCK IN IMUN AND MOVE ON. ITL SOON WILL NEED YOUR MONEY FOR THERE LAWYERS. IT MAKES NO SENSE TO HOLD ON. YOU
BELIEVE THESE 2 GUYS ARE CROOKS. MOVE ON.
BLACKCAT7717
MHB Stop with the BULL. Dr. Gruenberg or Dr. Har-Noy or whoever you are.
Sell your shares in IMUN and send A check to Dr. Gruenberg.
or ITL. He has the Allostim.
Blackcat7717
TO ALL INVESTORS: I am totally confused why MHB, Geo7, and Oceanlow1 are attempting to destroy Seth Shaw, Antonio Treminio and IMUN. They claim they own stock in IMUN. Ask yourself, what motive could they possibly have to destroy these 2 officers? If they are successful in destroying Shaw & Treminio they will be destroying IMUN at the same time. The stock would be priced below .04 cents with no one to run the company. Shareholders should be hoping that the current company officers spend their time wisely and make good acquisitions that will add shareholder value to IMUN.
I ask all shareholders to consider the following possibilities: (MHB, Geo7, & Oceanlow1)
A) These 3 individuals are getting information directly from(Dr. ?)Har-Noy who's past is ONLY a 10 year jail sentence.
compared to Seth Shaw & Antonio Treminio. I cannot find any information that these 2 ever spent 1 day in jail.
B) Could these 3 individuals be SHORT this stock and need to replace these shares soon because they are paying interest on the shares they borrowed.
C) Could they be heavily invested in ITL and stand to loose a great deal of money if ITL is proven to be a FRAUD? What will happen to ITL if IMUN recovers the 4 million dollars that they gave to ITL from IMUN shareholders? Wouldn't there investment in ITL be worth almost nothing?
D) They claim this is a Pump & Dump. The only person who benefited financially from this alleged P & D is Dr. Har-Noy and ITL. They received 4 Million Dollars of the 7 Million raised. Dr. Har-Noy filed the Wrongful Termination Notice to IMUN after IMUN refused to give any more shareholders money without proof of the FDA hold being lifted or at least the posting of the 42 patients that were studied in Carlsbad Calif. trials for peer review in a medical journal. (FOLLOW THE MONEY). WHERE IS OUR 4 MILLION DOLLARS?
I think these 3 should sell all their shares in IMUN.
Remember an empty shell is worth at least $.10 cents a share, because of the financial cost of going Public.
I am Long and Strong an buying more.
Blackcat7717
Johnny- It sounds like Ocean & MHB both have a stake in ITL & IMUN. Ocean or MHB might be connected to influence a settlement. I hope they are successful. It would be great if ITL & IMUN could both meet on common ground. It is so quiet on this board I can hear crickets. Happy to see everyone is calming down.
Blackcat7717
To All Investors: It looks like we are not going out of business.
Press Release
Immunovative, Inc. Actively Seeking Potential Acquisition Targets in the Biotechnology Space
NEW YORK, NY -- (Marketwire) -- 01/28/13 -- Immunovative, Inc. (OTCQB: IMUN) ("IMUN" or "The Company") today announced that the Company is actively seeking potential acquisition targets in the biotechnology sector. The Company is hopeful that future shareholder value can be created through such business activity. As previously reported, Immunovative Therapies, Ltd. ("ITL") served notice that it had terminated the December 2011 License Agreement between ITL and IMUN; this termination frees IMUN to evaluate and potentially acquire other targets in the biotechology sector. In light of this development, the Company, as of this morning, has taken down its corporate website (www.imun.com) and will likely seek a name and symbol change at some point in the future.
IMUN CEO Seth M. Shaw said, "The Company and its management is fully committed to both restoring and creating shareholder value moving forward. There are some intriguing opportunities in the biotechnology space and we are currently considering several business plans. IMUN is looking forward to the future with shareholders' best interests in heart. However, IMUN also will spare no expense to preserve existing shareholder value through litigation with ITL in federal court."
About Immunovative, Inc.: On December 12th, 2011, Immunovative, Inc. signed an exclusive License Agreement (the "License Agreement") with Immunovative Therapies, Ltd. Under the terms of the License Agreement, IMUN has been granted an exclusive, worldwide license to commercialize any products covered under ITL's current issued and pending patent application portfolio, as well as the rights to any future patent applications, including improvements or modifications to the existing applications and any corresponding improvements or new versions of the existing products. On January 8, 2013, IMUN received a notice from ITL purporting to terminate the License Agreement.
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on IMUN's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which IMUN has little or no control. Such forward-looking statements are made only as of the date of this release, and IMUN assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by IMUN with the Securities and Exchange Commission.
For more information please contact:
Mr. Seth M. Shaw
Chairman & Chief Executive Officer
Immunovative, Inc.
New York: +1-917-796-9926
Montreal: +1-514-840-3697
Blackcat7717
To all investors:
Did any one on this board know about Dr. Harnoy's past other than MHB?
Does anyone think it matters? Would you have invested if you knew?
MHB get the DR. to come to the table pronto. We must save this deal.
Blackcat7717